Current Region: North America
Your selections will be saved and used to recommend products based on your interests.
DIA brings together the world’s leading experts to discuss the most pressing issues related to medical product development. The output from these forums has resulted in the following coverage in a number of highly regarded media outlets.
EuroMeeting Report: INN Debate: IFPMA Pushes for Biosimilar Label Changes
EuroMeeting Report: Amgen Calls on Pharma to Educate Doctors on Biosimilars
EuroMeeting Report: Expert: 'We lack the regulatory models' for Next Generation Drugs
EuroMeeting Report: All Clinical Trials to be Published Under European Law
Venus bags UBM India Pharma Award for Elores
ASBM Presents New European Survey Findings on Biosimilars and the Importance of Nonproprietary Naming
Alzheimer’s Sessions at DIA 2013 focus on Challenges, Innovative Approaches in Drug Development
Combination Products: Everyone Wants to Be a Device
Theorem Clinical Research Releases the Online Version of Its Book "Smart Thinking," a Compilation of Theories by Industry Leaders
Evidence points to continuing medical value in orphan-drug industry incentives, says Makovsky Health
DIA’s 8th Annual Conference kicks-off in Bangalore
DIA 8th Annual event portrays promising prospects for clinical research industry
India to assume leadership status in clinical trials once govt accepts & implements expert panel recommendations: Prof. Ranjit Royc
Drug Information Association to Host Annual Canadian Meeting: New Realities/New Frontiers
DIA to Host 8th Annual Conference on The New Clinical Research Environment in India: Implications and Opportunities
Drug Information Association to Host 8th Annual Conference on the New Clinical Research Environment in India: Implications and Opportunities
CMS Needs Payment Reform Ideas For Rare Diseases From Private Sector - Former Official
Permission to post this story from Pink Sheet.
Economic Research Demonstrates Continued Value in Orphan Drug Act Incentives
Will Orphan Drug Reimbursement Policies Remain Stable?
Sticker Shock: Will Orphan Drug Reimbursement Remain Stable?
Patient Advocates to Share Stories of Challenges, Hope at DIA-NORD Conference
Drug Information Association to Host 10th Middle East Regulatory Conference
DIA Conference To Focus On Clinical Trial Disclosure And The Importance Of Transparency
U.S. Department of Health and Human Services Deputy Secretary to Present Keynote Address at Conference Hosted by DIA and NORD
Barbara Lopez Kunz Named DIA Global Chief Executive
No Differences in Quality of Clinical Trial Data Across Regions, Reports Drug Information Journal
DIA to Organise One-day Workshop on Imaging in Clinical Trials on July 27 in Bengaluru
Consumer Bodies Unanimously Support Implementation of System
Benchmark Initiates BioCLinica with Buy, $8 PT as Possible M&A Target
Nice Insight looks at outsourcing trends from drug developer POV
Research Study Management SaaS Offers Several Integration Tools.
Social Enterprise Compliance Software manages compliance risk.
New Mobile Healthcare Survey Reveals Mixed Bag
New Study Sponsored by Medidata Solutions Identifies Up to $5 Billion in Potential Clinical Trial Cost Savings
Clinical Trial App Could Save Time On Site Setup VideoClinical Trials Can Waste How Much Money?
FDA Commissioner: Patient Safety Must be Prioritized Over Job Creation
Supreme Court Predictions and Opinions on Disclosing Payments to Doctors
Updates from DIA 2012: “Collaborate to Innovate,” Says the Association
Drug and Food Safety Trumps Jobs, Say FDA’s Hamburg, Other Regulators
Drug Information Association Convention Here This Week
Drug Shortages are About Quality but Also About Price
Outsourcing Software for Clinical Trial Management Seeks to Cut Costs
Phlexglobal Repositions to Underline Trial Master File Expertise
Tufts Study Finds Unneeded Trial Data Being Collected
Survey: Future for Mobile Tech in Clinical Trials
FierceBiotechIT Lands in Philly for DIA
Life Sciences Key to Philadelphia Future (Op-Ed)
Pharma Giants Seek Temps as Start-up Funding Sags